Important changes to the MRC Clinical Trials Unit at UCL

From April 2026, the MRC Clinical Trials Unit at UCL will become the UCL Innovative Clinical Trials Unit.

The MRC Clinical Trials Unit at UCL has always been defined by its dedication to impactful research, innovation, its culture of collaboration and mentorship, and its commitment to improving global health. The Innovative Clinical Trials Unit is committed to continuing to fulfil the mission of smarter studies and global impact, leading to better health. We will continue to successfully deliver new and ongoing studies, collaborating with partners around the world. We will remain part of the Institute of Clinical Trials and Methodology at UCL. Sponsorship of Unit studies will remain unchanged. Our new name, branding and web address will launch in April 2026. For more information about the changes, visit https://www.mrcctu.ucl.ac.uk/news/news-stories/2026/february/mrc-clinical-trials-unit-at-ucl-to-become-the-ucl-innovative-clinical-trials-unit-from-april-2026/